StockData
Quest Diagnostics Inc logo

Quest Diagnostics Inc (DGX) stock

DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/3011% above fair value
$262.21+2.61 (+1.01%)

Close on Nov 16, 2026Market cap $28.85BP/E 26.1Yield –

Quest Diagnostics r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Quest Diagnostics

Quest Diagnostics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Quest Diagnostics figures

See a number that looks wrong?